Repeatability of (18)F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma

Quantitative 3′-deoxy-3′-(18)F-fluorothymidine ((18)F-FLT) PET has potential as a noninvasive tumor biomarker for the objective assessment of response to treatment. To guide interpretation of these quantitative data, we evaluated the repeatability of (18)F-FLT PET as part of a multicenter trial invo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Nucl Med
Hauptverfasser: Lodge, Martin A., Holdhoff, Matthias, Leal, Jeffrey P., Bag, Asim K., Nabors, L. Burt, Mintz, Akiva, Lesser, Glenn J., Mankoff, David A., Desai, Arati S., Mountz, James M., Lieberman, Frank S., Fisher, Joy D., Desideri, Serena, Ye, Xiaobu, Grossman, Stuart A., Schiff, David, Wahl, Richard L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Society of Nuclear Medicine 2017
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5331936/
https://ncbi.nlm.nih.gov/pubmed/27688473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.116.178434
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge